doxazosin

Generic: doxazosin

Labeler: major pharmaceuticals
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name doxazosin
Generic Name doxazosin
Labeler major pharmaceuticals
Dosage Form TABLET
Routes
ORAL
Active Ingredients

doxazosin mesylate 2 mg/1

Manufacturer
Major Pharmaceuticals

Identifiers & Regulatory

Product NDC 0904-5523
Product ID 0904-5523_ec0e1a20-88d4-457b-88fa-eff3071d0b9f
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075580
Listing Expiration 2026-12-31
Marketing Start 2011-07-14

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 09045523
Hyphenated Format 0904-5523

Supplemental Identifiers

RxCUI
197625 197626 197627
UNII
86P6PQK0MU

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name doxazosin (source: ndc)
Generic Name doxazosin (source: ndc)
Application Number ANDA075580 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 2 mg/1
source: ndc
Packaging
  • 100 BLISTER PACK in 1 CARTON (0904-5523-61) / 1 TABLET in 1 BLISTER PACK
source: ndc

Packages (1)

Ingredients (1)

doxazosin mesylate (2 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "ec0e1a20-88d4-457b-88fa-eff3071d0b9f", "openfda": {"unii": ["86P6PQK0MU"], "rxcui": ["197625", "197626", "197627"], "spl_set_id": ["3354196f-bbcf-4bc5-94f6-e6e8e132acb1"], "manufacturer_name": ["Major Pharmaceuticals"]}, "finished": true, "packaging": [{"sample": false, "description": "100 BLISTER PACK in 1 CARTON (0904-5523-61)  / 1 TABLET in 1 BLISTER PACK", "package_ndc": "0904-5523-61", "marketing_start_date": "20110714"}], "brand_name": "Doxazosin", "product_id": "0904-5523_ec0e1a20-88d4-457b-88fa-eff3071d0b9f", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "0904-5523", "generic_name": "Doxazosin", "labeler_name": "Major Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Doxazosin", "active_ingredients": [{"name": "DOXAZOSIN MESYLATE", "strength": "2 mg/1"}], "application_number": "ANDA075580", "marketing_category": "ANDA", "marketing_start_date": "20110714", "listing_expiration_date": "20261231"}